Page Updated: Saturday, August 08, 2026 11:06 AM ET

CNBC - Health

Cyclospora fears lead consumers to lose their appetite for salads

2 hours ago

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

1 day ago

Sen. Mitch McConnell says he's left rehab, will work from home

1 day ago

CAMP4 advances rare disease treatment for SYNGAP1 into human trials

1 day ago

Divide between Eli Lilly and Novo Nordisk is widening after latest earnings

1 day ago

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

2 days ago

This stock is more than a way to play GLP-1 boom

2 days ago

Bank of America spends $250M a year on GLP-1 drugs for its employees, CEO says

2 days ago

Eli Lilly blows past estimates, raises outlook on Zepbound and Mounjaro sales

3 days ago

CVS blows past estimates, hikes guidance as insurance unit continues to improve

3 days ago

Novo CEO defends economics of Wegovy pill as lower prices weigh on sales

3 days ago

Chipotle stock falls on potential link to salmonella outbreak in Minnesota

3 days ago

Novo Nordisk shares slide after guidance disappoints investors

3 days ago

P&G will acquire supplements brand Thorne for $3.8 billion, CEO tells CNBC

3 days ago

Pfizer tops estimates, hikes low end of revenue guidance on non-Covid products

3 days ago

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance

4 days ago

Michigan confirms first two deaths in cyclospora outbreak

4 days ago

AstraZeneca in talks with Bristol Myers Squibb on $400B megadeal, FT reports

4 days ago

Novo Nordisk shares dive after heart medicine fails trial in blow to pipeline

5 days ago

New Medicaid work rules could leave rare disease patients uninsured

8 days ago

AI stocks rebound, and why J&J's earnings guidance cut is not cause for concern

8 days ago

Hims and Hers shares fall 10% as FTC sues company over data, billing practices

9 days ago

Humana tops estimates, maintains profit outlook as medical costs stay in line

9 days ago

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

10 days ago

Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks instead

10 days ago

Kentucky Gov. Beshear calls on Mitch McConnell to prove he can serve or resign

10 days ago

McConnell still not cleared to go back to work as he recovers from fall: Doctors

10 days ago

Consolidated food supply may be worsening cyclospora outbreaks, experts say

11 days ago

FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business

11 days ago

Here are 4 forces that drove a tough week for stocks

13 days ago

CDC says massive cyclospora outbreak is now in nine states

14 days ago

Cyclospora outbreak tests RFK Jr.'s promise to overhaul food system

14 days ago